Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2000;82:141-143; doi:10.1136/adc.82.2.141
Copyright © 2000 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Arch Dis Child 2000;82:141-143 ( February )

Article

Immunisation against varicella in end stage and pre-end stage renal failure Nicholas J A Webba, Margaret M Fitzpatrickb, David A Hughesc, Trevor J Brocklebankb, Brian A Juddc, Malcolm A Lewisa, Robert J Postlethwaitea, Patricia A Smitha, Gerald Corbittd, on behalf of the Trans-Pennine Paediatric Nephrology Study Group

a Department of Paediatric Nephrology, Royal Manchester Children's Hospital, Pendlebury, Manchester M27 4HA, UK, b Department of Paediatric Nephrology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK, c Department of Paediatric Nephrology, Royal Liverpool Children's Hospital, Eaton Road, Liverpool L12 2AP, UK, d Department of Virology, Central Manchester Healthcare Trust, Oxford Road, Manchester M13 9WL, UK

Correspondence to: Dr Webb email: nwebb{at}lycosmail.com

Accepted 17 September 1999

OBJECTIVES---To investigate the seroconversion rate and duration of persistence of protective antibody titres after varicella immunisation in children with renal failure.
DESIGN---32 children (25 end stage and 7 pre-end stage renal failure) were immunised using 2 × 2000 plaque forming unit doses of varicella vaccine 3 months apart. Varicella antibody titres were measured by enzyme linked immunosorbent assay.
RESULTS---All children initially seroconverted after immunisation. At a mean follow up of 20.3 months, 23 of 28 had protective antibody titres, 4 children having died of unrelated causes. Two children required a third booster dose. 11 children underwent renal transplantation; 10 had protective titres at the time of transplantation and, at a mean of 23.4 months after immunisation, 6 currently have protective titres. Minor side effects occurred after 11 vaccine doses in 9 children. No child developed varicella, despite 10 clear episodes of exposure to the wild-type virus.
CONCLUSIONS---Varicella immunisation in children with end stage and pre-end stage renal failure results in a high rate of seroconversion and persistence of protective antibody titres. More widespread use of the vaccine before renal transplantation is recommended.


Keywords: immunisation; varicella; end stage kidney failure; renal transplantation


© 2000 by Archives of Disease in Childhood

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Janus, N., Vacher, L.-V., Karie, S., Ledneva, E., Deray, G. (2008). Vaccination and chronic kidney disease. Nephrol Dial Transplant 23: 800-807 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs